Skip to main content

ALC

Stock
Health Care
Medical Instruments & Supplies

Performance overview

ALC Price
Price Chart

Forward-looking statistics

Beta
0.76
Risk
22.39%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Alcon is an American Swiss medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees25K
Market cap$45.1B

Fundamentals

Enterprise value$47.6B
Revenue$9.9B
Revenue per employee—
Profit margin11.28%
Debt to equity23.63

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$2.25
Dividend per share$1.06
Revenue per share$20.06
Avg trading volume (30 day)$140M
Avg trading volume (10 day)$122M
Put-call ratio—

Macro factor sensitivity

Growth-0.9
Credit+8.7
Liquidity-2.6
Inflation-3.0
Commodities+0.3
Interest Rates-1.8

Valuation

Dividend yield1.20%
PEG Ratio24.94
Price to sales4.38
P/E Ratio24.94
Enterprise Value to Revenue4.79
Price to book1.98

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day—
Ex. dividend dayMay 14, 2025

News

Alcon Stock Gains Following UNITY VCS' Approval in Canada

ALC's UNITY VCS gets Canada's approval, advancing surgical precision with faster, more efficient technology.

Zacks Investment Research (July 9, 2025)
4 Agriculture Operations Stocks Riding Health Trends Amid Margin Woes

The Agriculture - Operations industry is gaining from healthy eating trends, innovation and global demand, but rising costs and trade risks pose challenges. CTVA, ADM, AVO and ALCO look promising.

Zacks Investment Research (July 3, 2025)
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Wednesday.

Benzinga (May 14, 2025)
Watch CNBC's full interview with Alcon CEO David Endicott

Alcon CEO David Endicott discusses the pharmaceutical firm's full-year results.

CNBC International TV (February 27, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free